Valeo Medical

Valeo Pharma is a Canadian specialty pharmaceutical company focused on the commercialization of innovative prescription products. The company targets several therapeutic areas, including respiratory health, neurology, oncology, and specialty hospital products. Its portfolio includes key products such as Redesca (enoxaparin), Enerzair Breezhaler, and Onstryv (safinamide). Valeo Pharma operates by in-licensing products from global partners and managing their regulatory approval and commercial distribution in the Canadian market. The company is publicly traded on the Canadian Securities Exchange and has established a significant commercial infrastructure to support its growing portfolio of specialty drugs.